TSX:CRONPharmaceuticals
Cronos Group Q1 Profit Of US$13.8 Million Tests Skeptical Earnings Narratives
Cronos Group (TSX:CRON) opened 2026 with Q1 revenue of US$45.2 million and basic EPS of US$0.04, alongside trailing twelve month revenue of US$159.5 million and a small net loss of US$1.8 million. Over recent quarters the company has seen revenue move from US$30.3 million in Q4 2024 to US$32.3 million in Q1 2025 and US$45.2 million in Q1 2026, while basic EPS has ranged from a loss of US$0.10 in Q2 2025 to a profit of US$0.11 in Q4 2024 and US$0.04 in the latest quarter. This points to a...